Research highlights advanced imaging analytics that may support Alzheimer's disease monitoring, patient stratification, and future therapeutic development. POTOMAC, MD / ACCESS Newswire / May 15, 2026 ...
Dish,” to test anti-amyloid therapies. The approach has already been used to screen thousands of compounds and enables more ...
More than 80% of no-option chronic limb-threatening ischemia patients avoided amputation for 6 months after the procedure ...
Scinai Immunotherapeutics Ltd. , ("Scinai" or the "Company") a biopharmaceutical company focused on inflammation and immunology, today announced that members of its leadership team will lead a ...
NetraMark Holdings Inc. (the "Company" or "NetraMark") (TSX: AIAI) (OTCQB: AINMF) (Frankfurt: PF0) a premier artificial intelligence (AI) company that is transforming ...
Managing waiting lists is a constant balancing act, and the relatively low rate of malignant progression to cancer in Barrett’s patients must also be considered. The vast majority of surveillance ...
Discusses Extended Follow-Up Data From Phase 3 Trial of aglatimagene besadenovec in Localized Prostate Cancer May 15, ...
New EULAR recommendations for the management of rheumatoid arthritis stress that disease-modifying antirheumatic drugs should ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results